Human timp-1 antibodies
CA 2445168 A1 · Owner: Bayer Corporation · Inventors: Krebs, Barbara; Hirth-Dietrich, Claudia; Schauer, Michael
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Human antibodies that bind to TIMP-1 can be used as reagents to diagnose and treat disorders in which TIMP-1 is elevated such as liver fibrosis, alcoholic , liver disease cardiac fibrosis, acute coronary syndrome lupus nephritis, glomerulosclerotic renal disease benign prostate hypertrophy, colon cancer lung cancer, and idiopathic pulmonary fibrosis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 24, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 24, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 24, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.